140th ENMC International Workshop: Myotonic Dystrophy DM2/PROMM and other myotonic dystrophies with guidelines on management
Bjarne Udd(Folkhälsans Forskningscentrum), Richard T. Moxley(Unknown), Charles A. Thornton(University of Rochester Medical Center), Benedikt Schoser(Friedrich Baur Stiftung), Guillaume Bassez(Centre Hospitalier Universitaire Henri-Mondor), Ralf Krahe(University of Helsinki), G. Meola(IRCCS Policlinico San Donato), Laura P.W. Ranum(Allen Institute for Brain Science)
Cited by 107
Related Papers
Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1
|Nature Genetics|1993|1.7k
Non-ATG–initiated translation directed by microsatellite expansions
|Proceedings of the National Academy of Sciences|2010|912
Randomized, Double-Blind Six-Month Trial of Prednisone in Duchenne's Muscular Dystrophy
|New England Journal of Medicine|1989|518
The myotonic dystrophies: molecular, clinical, and therapeutic challenges
|The Lancet Neurology|2012|487
Tibial Muscular Dystrophy Is a Titinopathy Caused by Mutations in TTN, the Gene Encoding the Giant Skeletal-Muscle Protein Titin
|The American Journal of Human Genetics|2002|484